Medindia

X

Thoratec Presentation at Bank of America Conference to be Webcast

Saturday, May 7, 2011 General News J E 4
Advertisement

PLEASANTON, Calif., May 6, 2011 /PRNewswire/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Bank of America Merrill Lynch 2011 Health Care Conference on Wednesday, May 11.

David V. Smith, executive vice president and chief financial officer, will provide an update on the company, beginning at 8:40 a.m., Pacific Daylight Time (11:40 a.m., Eastern Daylight Time).

The presentation will be available through the conference website at https://www.veracast.com/webcasts/baml/healthcare2011/id46649100.cfm, or on the company's web site at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web site at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation.

SOURCE Thoratec Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
American Oriental Bioengineering to Announce First...
S
ONCOTHYREON REPORTS FIRST QUARTER 2011 FINANCIAL R...